Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stannous Fluoride Dentifrice for Gingivitis and Plaque Reduction
NCT06143670Completed
- Sponsor
- Haleon
- Start
- Nov 2023
- Primary completion
- Mar 2024
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Randomised, single-blind trial of stannous fluoride in gingivitis and dental plaque (2 arms), sponsored by Haleon. Primary endpoint: Adjusted Mean Change From Baseline in the Number of Bleeding Sites at 12 weeks. Started Nov 2023; status: completed.
02
Drugs
stannous fluoride
03
Conditions
gingivitisdental plaque
Beyond the preview
Go deeper on NCT06143670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06143670.